CellaVision AB (C26) Stock Statistics & Valuation Metrics
Total Valuation
CellaVision AB has a market cap or net worth of EUR 423.70M. The enterprise value is EUR 3.96B.
- Market Cap
- EUR 423.70M
- Enterprise Value
- EUR 3.96B
Share Statistics
CellaVision AB has 23,851,547 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 23,851,547
- Owned by Insiders
- ―
- Owned by Institutions
- 1.28%
Financial Efficiency
CellaVision AB’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 15.96%.
- Return on Equity (ROE)
- 0.17
- Return on Assets (ROA)
- 0.14
- Return on Invested Capital (ROIC)
- 15.96%
- Return on Capital Employed (ROCE)
- 0.21
- Revenue Per Employee
- 3.02M
- Profits Per Employee
- 609.87K
- Employee Count
- 251
- Asset Turnover
- 0.69
- Inventory Turnover
- 2.14
Valuation Ratios
The current PE Ratio of CellaVision AB is 33.84. CellaVision AB’s PEG ratio is -3.77.
- PE Ratio
- 33.84
- PS Ratio
- 6.11
- PB Ratio
- 5.00
- Price to FCF
- 30.10
- Price to Operating Cash Flow
- 22.10
- PEG Ratio
- -3.77
Income Statement
In the last 12 months, CellaVision AB had revenue of 758.97M and earned 153.08M in profits. Earnings per share was 6.42.
- Revenue
- 758.97M
- Gross Profit
- 519.88M
- Operating Income
- 202.07M
- Pretax Income
- 194.26M
- Net Income
- 153.08M
- EBITDA
- 237.28M
- Earnings Per Share (EPS)
- 6.42
Cash Flow
In the last 12 months, operating cash flow was 211.07M and capital expenditures -56.10M, giving a free cash flow of 154.97M billion.
- Operating Cash Flow
- 211.07M
- Free Cash Flow
- 154.97M
- Free Cash Flow per Share
- 6.50
Dividends & Yields
CellaVision AB pays an annual dividend of ―, resulting in a dividend yield of 1.50%
- Dividend Per Share
- ―
- Dividend Yield
- 1.50%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 3.32%
- Earnings Yield
- 2.96%
Stock Price Statistics
- Beta
- 0.79
- 52-Week Price Change
- 7.44%
- 50-Day Moving Average
- 14.63
- 200-Day Moving Average
- 13.24
- Relative Strength Index (RSI)
- 81.15
- Average Volume (3m)
- 206
Important Dates
CellaVision AB upcoming earnings date is Feb 04, 2027, Before Open (Not Confirmed).
- Last Earnings Date
- Oct 29, 2026
- Next Earnings Date
- Feb 04, 2027
- Ex-Dividend Date
- ―
Financial Position
CellaVision AB as a current ratio of 3.98, with Debt / Equity ratio of 2.89%
- Current Ratio
- 3.98
- Quick Ratio
- 2.97
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- -0.69
- Interest Coverage Ratio
- 18.86
Taxes
In the past 12 months, CellaVision AB has paid 41.19M in taxes.
- Income Tax
- 41.19M
- Effective Tax Rate
- 0.21
Enterprise Valuation
CellaVision AB EV to EBITDA ratio is 21.46, with an EV/FCF ratio of 29.02.
- EV to Sales
- 5.89
- EV to EBITDA
- 21.46
- EV to Free Cash Flow
- 29.02
- EV to Operating Cash Flow
- 21.30
Balance Sheet
CellaVision AB has EUR 218.54M in cash and marketable securities with EUR 49.81M in debt, giving a net cash position of EUR 168.72M billion.
- Cash & Marketable Securities
- EUR 218.54M
- Total Debt
- EUR 49.81M
- Net Cash
- EUR 168.72M
- Net Cash Per Share
- EUR 7.07
- Tangible Book Value Per Share
- EUR 15.54
Margins
Gross margin is 68.01%, with operating margin of 22.97%, and net profit margin of 18.08%.
- Gross Margin
- 68.01%
- Operating Margin
- 22.97%
- Pretax Margin
- 22.93%
- Net Profit Margin
- 18.08%
- EBITDA Margin
- 27.47%
- EBIT Margin
- 23.12%
Analyst Forecast
The average price target for CellaVision AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 4.59%
- EPS Growth Forecast
- -6.64%